Colorcon
North America, Pennsylvania, United States, Harleysville
Description
Colorcon specializes in the design and development of specialty excipients for solid oral dosages for the pharmaceutical.
Investor Profile
Colorcon has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
Stage Focus
- Series A (50%)
- Series B (50%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Nutraceutical
- Artificial Intelligence (Ai)
- Machine Learning
- Medical
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
